Stay updated with breaking news from Nirali Shah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dhwani Shah, a student of Navrachana Higher Secondary School (NHSS), Sama, has emerged as the topper in the class 12 science stream by securing 98.6% in the CBSE results. Learn about her journey and aspirations to follow in her parents' footsteps in the medical field.
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country's pharmaceuticals sector. Sanofi's partnerships with Dr Reddy's, Cipla, and Emcure, AstraZeneca and Mankind Pharma - teaming up for asthma medication distribution - are a few instances of this trend. This strategy allows MNCs to leverage established Indian networks and reach a wider audience. Indian companies also benefit from global brands and expertise, say analysts.
From curiosity to groundbreaking cure: How a team in India developed a game-changing cancer therapy. You won't believe the results!
A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.
What Dubai does not require is being selectively targeted by some global entities